1. Home
  2. BHRB vs COLL Comparison

BHRB vs COLL Comparison

Compare BHRB & COLL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BHRB
  • COLL
  • Stock Information
  • Founded
  • BHRB 1852
  • COLL 2002
  • Country
  • BHRB United States
  • COLL United States
  • Employees
  • BHRB N/A
  • COLL N/A
  • Industry
  • BHRB Major Banks
  • COLL Biotechnology: Pharmaceutical Preparations
  • Sector
  • BHRB Finance
  • COLL Health Care
  • Exchange
  • BHRB Nasdaq
  • COLL Nasdaq
  • Market Cap
  • BHRB 852.6M
  • COLL 958.8M
  • IPO Year
  • BHRB N/A
  • COLL 2015
  • Fundamental
  • Price
  • BHRB $62.90
  • COLL $38.32
  • Analyst Decision
  • BHRB Strong Buy
  • COLL Strong Buy
  • Analyst Count
  • BHRB 3
  • COLL 4
  • Target Price
  • BHRB $71.67
  • COLL $44.25
  • AVG Volume (30 Days)
  • BHRB 46.4K
  • COLL 427.8K
  • Earning Date
  • BHRB 10-24-2025
  • COLL 08-07-2025
  • Dividend Yield
  • BHRB 3.50%
  • COLL N/A
  • EPS Growth
  • BHRB N/A
  • COLL N/A
  • EPS
  • BHRB 6.89
  • COLL 1.06
  • Revenue
  • BHRB $330,001,000.00
  • COLL $707,007,000.00
  • Revenue This Year
  • BHRB $51.44
  • COLL $22.23
  • Revenue Next Year
  • BHRB $3.58
  • COLL $2.78
  • P/E Ratio
  • BHRB $9.12
  • COLL $36.58
  • Revenue Growth
  • BHRB 164.69
  • COLL 22.61
  • 52 Week Low
  • BHRB $47.57
  • COLL $23.23
  • 52 Week High
  • BHRB $75.32
  • COLL $42.29
  • Technical
  • Relative Strength Index (RSI)
  • BHRB 56.20
  • COLL 59.51
  • Support Level
  • BHRB $62.44
  • COLL $38.00
  • Resistance Level
  • BHRB $64.24
  • COLL $39.78
  • Average True Range (ATR)
  • BHRB 1.40
  • COLL 0.97
  • MACD
  • BHRB 0.21
  • COLL -0.18
  • Stochastic Oscillator
  • BHRB 76.02
  • COLL 38.72

About BHRB Burke & Herbert Financial Services Corp.

Burke & Herbert Financial Services Corp is the bank holding company. Through its subsidiary, it predominantly serves small to medium-sized businesses, their owners and employees, professional corporations, non-profits, and individuals with various banking products and financial services. Some of its products and service offerings include checking, savings, and money market accounts, certificates of deposit, treasury and cash management services, commercial and industrial loans, commercial real estate loans, residential mortgage, acquisition, construction, and development loans, online banking, mobile banking, and wealth and trust services. The company operates in a single segment, namely Community Banking.

About COLL Collegium Pharmaceutical Inc.

Collegium Pharmaceutical Inc is a specialty pharmaceutical company. The company is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is designed to maintain the extended-release and safety profiles of abused drugs in the face of various methods including chewing, crushing, and dissolving. Its product portfolio includes Jornay, Xtampza ER, which is an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta Products, which are extended-release and immediate-release formulations of tapentadol; Belbuca, and Symproic.

Share on Social Networks: